Leinco Technologies

Leinco Technologies is a well-established, privately-held provider of research antibodies, recombinant proteins, and custom bioproduction services. The company's core business model combines a catalog of off-the-shelf research tools with a significant custom services division, including antibody development, conjugation, and large-scale manufacturing for diagnostics (IVD). With a focus on quality and reproducibility, Leinco serves the global life sciences market, positioning itself as a critical supplier for both basic research and diagnostic assay development. Its recent expansion into areas like spatial biology (CODEX), biosimilars, and tissue clearing kits demonstrates a strategic evolution beyond its traditional antibody roots.

Suite of antibody/protein development and manufacturing technologies including hybridoma development, recombinant expression, single B-cell sequencing for rabbit mAbs, specialized conjugation (NIR-SHIELD, oligonucleotide), and CHO cell bioproduction.

Leinco competes in the crowded research antibodies and proteins market against giants like Thermo Fisher Scientific, Abcam, and Bio-Techne, as well as numerous niche players. Its differentiation lies in its strong custom services arm, ISO-certified US manufacturing, and specialized offerings for in vivo studies and IVD development, which may provide an edge in service quality and client collaboration over larger, less flexible competitors.